Angela Cendron

Title: Angela Cendron: Innovator in Peptide Inhibitors

Introduction

Angela Cendron is a notable inventor based in Campbellfield, Australia. She has made significant contributions to the field of biochemistry, particularly in the development of peptide inhibitors. Her work focuses on innovative solutions that have the potential to impact cancer research and treatment.

Latest Patents

Angela Cendron holds a patent for a VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor. This patent describes monomeric monocyclic peptide inhibitors and dimeric bicyclic peptide inhibitors based on exposed loop fragments of a growth factor protein, such as loop 1, 2, or 3 of VEGF-D. The patent also details methods of making these inhibitors, as well as pharmaceutical compositions containing them and methods utilizing them.

Career Highlights

Angela is affiliated with the Ludwig Institute for Cancer Research Limited, where she continues her research and development efforts. Her work is crucial in advancing the understanding of growth factor proteins and their role in cancer.

Collaborations

Angela has collaborated with notable colleagues, including Marc Gregory Achen and Richard A Hughes. These collaborations enhance the research efforts and contribute to the advancement of cancer therapies.

Conclusion

Angela Cendron is a pioneering inventor whose work in peptide inhibitors is making strides in cancer research. Her innovative approaches and collaborations are paving the way for future advancements in the field.